Hangzhou Aichek Medical Technology Co.,Ltd
| Payment Terms | T/T |
| Supply Ability | negotiable |
| Packaging Details | 40box/carton |
| Storage | 2℃-30℃ |
| User | Everyone |
| Accuracy | 99.05% (95% CI: 97.58%~99.63%) |
| Certificate | CE ISO 13485 |
| Key words | 2019-nCov neutralizing Antibody Rapid Test Kit |
| OEM | OEM customized packing avaliable |
| Formats | 25T/box 1T/box |
| Sample | Blood |
| Brand Name | Aichek |
| Model Number | COVID-19-G02001A |
| Certification | CE |
| Place of Origin | China |
View Detail Information
Explore similar products
Nab Rtk Blood Test Neutralizing Antibody Rapid Test Kit Cov-19
Nab In Blood NAbs Test ISO 13485 Neutralizing Antibody Test Kit
CE 99% Neutralizing Antibody Test Kit 25T / Box For Hospital
2019-NCov Neutralizing Antibody Rapid Test Kit Double Check
Product Specification
| Payment Terms | T/T | Supply Ability | negotiable |
| Packaging Details | 40box/carton | Storage | 2℃-30℃ |
| User | Everyone | Accuracy | 99.05% (95% CI: 97.58%~99.63%) |
| Certificate | CE ISO 13485 | Key words | 2019-nCov neutralizing Antibody Rapid Test Kit |
| OEM | OEM customized packing avaliable | Formats | 25T/box 1T/box |
| Sample | Blood | Brand Name | Aichek |
| Model Number | COVID-19-G02001A | Certification | CE |
| Place of Origin | China | ||
| High Light | 25pcs Neutralizing Antibody Rapid Test ，Blood Neutralizing Antibody Rapid Test ，neutralization antibody detection kit | ||
2019-nCov neutralizing Antibody Rapid Test Kit
For professional and in vitro diagnostic use only.
| Product Name | 2019-nCov neutralizing Antibody Rapid Test Kit |
| Formats | Strip(3mm)Device(4mm) uncut sheet |
| Place of Origen | China |
| Specimen | Blood |
| Read Time | 15 minutes |
| Shelf life | 2 years |
| Package | 25T/Box |
| Storage | 2℃-30℃ |
For professional and in vitro diagnostic use only.
[INTENDED USE]
The product is suitable for qualitative detection of neutralizing antibodies (NAbs) against SARS-CoV-2 that block the interaction between the receptor binding domain (RBD) of the spike glycoprotein and the Angiotensin converting enzyme Ⅱ (ACE2) receptor. The device can be instrumental in vaccine and therapeutic development as it is suitable for all antibody isotypes. It may also help in current COVID-19 investigations of sero-prevalence, assessment of human immunity, longevity of protective immunity, efficacy of different vaccine candidates as well as tracking infection.
[PERFORMANCE CHARACTERISTICS]
Sensitivity
The sensitivity to S-mIgG1 neutralizing antibody can reach 2ug/mL.
Accuracy
A side-by-side comparison was conducted by the results of SARS-Cov-2 Neutralizing Antibody Test Device (Test Reagent) developed by Hangzhou Deangel Biological Engineering Co., Ltd. and cPassTM from Genscript CO., Ltd. 328 clinical specimens from Professional Point of Care site were evaluated, 105 were positive and others negative. Base on the results from the clinical studies, the statistical analysis was made as follows:
| cPassTM | Total | |||
| Positive | Negative | |||
| Test reagent | Positive | 96 | 2 | 98 |
| Negative | 9 | 221 | 230 | |
| Total | 105 | 223 | 328 | |
For test reagent, the clinical sensitivity with the “Compared Reagent” was 91.4% (95% CI: 77.7%~100%), the clinical specificity was 99.1% (95% CI: 97.2%~100%), the coincidence rate was 96.6% (95% CI: 92.4%~100%).
[PRINCIPLE]
The Device uses the principle of the Surrogate Virus Neutralization Test method for detecting the neutralizing antibody against SARS-CoV-2 in human/animal specimens. The marker is composed of the recombinant spike glycoprotein (SP) labeled with Dye. When testing, the specimen was added into the sample well and migrated to the absorbent pad by the capillary effect. If there are enough NAbs contained in the specimen, it will react with the marker and block the marker captured by the ACE2 coated in the NC membrane. Then there is no colored line produced at the test area (T), indicating a positive result. If the NAbs not enough, the test region will show weak T line. If there are no NAbs, the T line will show and it means a negative result. Regardless of whether the Nab exists, as a procedural control, a colored line will always appear at the control area (C), indicating that proper volume of specimen has been added and the correct test procedure is conducted.
Company Details
Business Type:
Manufacturer
Year Established:
2012
Total Annual:
500000-1000000
Employee Number:
150~200
Ecer Certification：
Active Member
Hangzhou Aichek Medical Technology Co.,Ltd Hangzhou Aichek Medical Technology Co.,Ltd is a high-tech company specialises in manufacturing rapid diagnostic and healthcare products. With five product lines of fertility, infectious diseases, cardiac marker, tumor marker and drug of... Hangzhou Aichek Medical Technology Co.,Ltd Hangzhou Aichek Medical Technology Co.,Ltd is a high-tech company specialises in manufacturing rapid diagnostic and healthcare products. With five product lines of fertility, infectious diseases, cardiac marker, tumor marker and drug of...
Get in touch with us
Leave a Message, we will call you back quickly!